1. Peng, Xianglan, He, Dong, Peng, Rui, Chen, Yang, He, Hong. 2023. Associations between IGFBP1 gene polymorphisms and the risk of preeclampsia and fetal growth restriction. In Hypertension research : official journal of the Japanese Society of Hypertension, 46, 2070-2084. doi:10.1038/s41440-023-01309-8. https://pubmed.ncbi.nlm.nih.gov/37217731/
2. Cheng, Yuning, Yang, Ruixiang, Zhou, Yue, Jiang, Wei, Zhang, Xiaowei. 2022. HBP1 inhibits the development of type 2 diabetes mellitus through transcriptional activation of the IGFBP1 gene. In Aging, 14, 8763-8782. doi:10.18632/aging.204364. https://pubmed.ncbi.nlm.nih.gov/36326689/
3. Li, Yunyun, Yang, Xuelian, Han, Tao, Wu, Jing, Hu, Dong. 2024. IGFBP1 promotes the proliferation and migration of lung adenocarcinoma cells through the PPARα pathway. In Translational oncology, 49, 102095. doi:10.1016/j.tranon.2024.102095. https://pubmed.ncbi.nlm.nih.gov/39167955/
4. Tang, Qing, Zheng, Fang, Wu, JingJing, Li, Liuning, Hann, Swei Sunny. 2017. Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1. In Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 43, 2310-2326. doi:10.1159/000484383. https://pubmed.ncbi.nlm.nih.gov/29073599/
5. Hivert, Marie-France, White, Frederique, Allard, Catherine, Karumanchi, S, Powe, Camille. 2023. Placental RNA sequencing implicates IGFBP1 in insulin sensitivity during pregnancy and in gestational diabetes. In Research square, , . doi:10.21203/rs.3.rs-3464151/v1. https://pubmed.ncbi.nlm.nih.gov/37961187/
6. Luo, Xiao-Ye, Zhang, Yan-Ping, Zheng, Feng, Zhou, Liang. . Multiple bioinformatics analysis identifies IGFBP1 as associated with the prognosis of stomach adenocarcinoma. In Medicine, 102, e33346. doi:10.1097/MD.0000000000033346. https://pubmed.ncbi.nlm.nih.gov/37000073/